As there are some limitations in using luciferase as a reporter gene in the clinical setting, we further plan to develop oncolytic viruses capable of imaging and treating cancer at the same time using a clinically relevant imaging modality like HSV-TK and SPECT-CT. The gene discussed is TKT; the disease is cancer.